Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Tissue Regeneration Technologies, LLC has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 3 actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution indicates that the company's active cases are being handled by a small, focused group of examiners within the patent office. With 2 distinct art units involved, the company's prosecution efforts are spread across specialized technical divisions.
Sean A Frith is the busiest examiner for the portfolio, currently managing 2 pending office actions. This accounts for a majority of the 3 total pending actions for the company. The remaining pending action is assigned to the other distinct examiner. Practitioners should note the concentration of cases under a single examiner while also addressing the requirements of the other art unit. This profile requires coordination between 2 distinct examiners to manage the 3 pending office actions effectively.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRITH, SEAN A | 2 | 62.5% | +26.7% |
| PINDERSKI, JACQUELINE M | 1 | 26.9% | +45.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18472609 | ACOUSTIC SHOCK WAVE THERAPEUTIC METHODS TO CORRECT ARRHYTHMIA | PINDERSKI, JACQUELINE M | 12d |
| 19402806 | DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR-DESTRUCTIVE MECHANICAL PULSES (TMI) | FRITH, SEAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18462551 | DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR - DESTRUCTIVE MECHANICAL PULSES (TMI) | FRITH, SEAN A | 87d overdue |
| 18472609 | ACOUSTIC SHOCK WAVE THERAPEUTIC METHODS TO CORRECT ARRHYTHMIA | PINDERSKI, JACQUELINE M | 12d |
| 19402806 | DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR-DESTRUCTIVE MECHANICAL PULSES (TMI) | FRITH, SEAN A | — |
| Art Unit | Apps |
|---|---|
| 3798 | 2 |
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19402806 | DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR-DESTRUCTIVE MECHANICAL PULSES (TMI) | FRITH, SEAN A | 3798 | §103§112 | Non-Final OA | — | Pending | Nov 26, 2025 |
| 18472609 | ACOUSTIC SHOCK WAVE THERAPEUTIC METHODS TO CORRECT ARRHYTHMIA | PINDERSKI, JACQUELINE M | 3785 | §103§112 | Final Rejection | 12d | Pending | Sep 22, 2023 |
| 18462551 | DEVICE FOR TREATING MALIGNANT DISEASES WITH THE HELP OF TUMOR - DESTRUCTIVE MECHANICAL PULSES (TMI) | FRITH, SEAN A | 3798 | §103 | Final Rejection | 87d overdue | Pending | Sep 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial